Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F W Ruscetti

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
The Journal of Experimental Medicine|August 1, 1988
Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell linesJ R Keller, C Mantel, G K Sing, et al.
The Journal of Experimental Medicine|September 1, 1990
Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 actionC M Dubois, F W Ruscetti, E W Palaszynski, et al.
Blood|December 1, 1991
In vivo interleukin-1 (IL-1) administration indirectly promotes type II IL-1 receptor expression on hematopoietic bone marrow cells: novel mechanism for the hematopoietic effects of IL-1C M Dubois, F W Ruscetti, J R Keller, et al.
Blood|July 1, 1994
Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptorK Hestdal, F W Ruscetti, R Chizzonite, et al.
The New England Journal of Medicine|August 1, 1985
Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosisP M Hoffman, B W Festoff, L T Giron, et al.
In Vivo (Athens, Greece)|November 7, 2001
Hematopoietic switch from lymphoid to granulocytic development in 3LL tumor-bearing miceJ K Lee, T C Back, K L Komschlies, et al.
The Journal of Experimental Medicine|June 1, 1995
Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cellsK W Muszynski, F W Ruscetti, G Heidecker, et al.
Experimental Hematology|October 1, 1994
Distinct and direct synergistic effects of IL-1 and IL-6 on proliferation and differentiation of primitive murine hematopoietic progenitor cells in vitroS E Jacobsen, F W Ruscetti, C Okkenhaug, et al.
Cancer Research|July 1, 1997
Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activityJ M Turley, F W Ruscetti, S J Kim, et al.
Blood|June 1, 1994
Inhibitory cytokine circuits involving transforming growth factor-beta, interferon-gamma, and interleukin-2 in human monocyte activationI Espinoza-Delgado, M C Bosco, T Musso, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
The Journal of Experimental Medicine|August 1, 1988
Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell linesJ R Keller, C Mantel, G K Sing, et al.
The Journal of Experimental Medicine|September 1, 1990
Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 actionC M Dubois, F W Ruscetti, E W Palaszynski, et al.
Blood|December 1, 1991
In vivo interleukin-1 (IL-1) administration indirectly promotes type II IL-1 receptor expression on hematopoietic bone marrow cells: novel mechanism for the hematopoietic effects of IL-1C M Dubois, F W Ruscetti, J R Keller, et al.
Blood|July 1, 1994
Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptorK Hestdal, F W Ruscetti, R Chizzonite, et al.
The New England Journal of Medicine|August 1, 1985
Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosisP M Hoffman, B W Festoff, L T Giron, et al.
In Vivo (Athens, Greece)|November 7, 2001
Hematopoietic switch from lymphoid to granulocytic development in 3LL tumor-bearing miceJ K Lee, T C Back, K L Komschlies, et al.
The Journal of Experimental Medicine|June 1, 1995
Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cellsK W Muszynski, F W Ruscetti, G Heidecker, et al.
Experimental Hematology|October 1, 1994
Distinct and direct synergistic effects of IL-1 and IL-6 on proliferation and differentiation of primitive murine hematopoietic progenitor cells in vitroS E Jacobsen, F W Ruscetti, C Okkenhaug, et al.
Cancer Research|July 1, 1997
Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activityJ M Turley, F W Ruscetti, S J Kim, et al.
Blood|June 1, 1994
Inhibitory cytokine circuits involving transforming growth factor-beta, interferon-gamma, and interleukin-2 in human monocyte activationI Espinoza-Delgado, M C Bosco, T Musso, et al.
Pageof 22